User menu

CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.

Bibliographic reference Rousseau, Emmanuel ; Ruchoux, M-M ; Scaravilli, F. ; Chapon, F ; Vinchon, M ; et. al. CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.. In: Neuropathology and applied neurobiology, Vol. 29, no. 6, p. 574-83 (2003)
Permanent URL
  1. Baylin S. B., Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer, 10.1093/hmg/10.7.687
  2. Baylin Stephen B, Herman James G, DNA hypermethylation in tumorigenesis: epigenetics joins genetics, 10.1016/s0168-9525(99)01971-x
  3. Belinsky S. A., Nikula K. J., Palmisano W. A., Michels R., Saccomanno G., Gabrielson E., Baylin S. B., Herman J. G., Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis, 10.1073/pnas.95.20.11891
  4. Bortolotto Simona, Chiadò-Piat Loredana, Cavalla Paola, Bosone Ivana, Mauro Alessandro, Schiffer Davide, 10.1023/a:1012537105775
  5. Boström Jan, Meyer-Puttlitz Birgit, Wolter Marietta, Blaschke Britta, Weber Ruthild G., Lichter Peter, Ichimura Koichi, Collins V. Peter, Reifenberger Guido, Alterations of the Tumor Suppressor Genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in Atypical and Anaplastic Meningiomas, 10.1016/s0002-9440(10)61737-3
  6. Bouvier-Labit, Civatte, Bartoli, Renaud, Pellissier, Figarella-Branger, p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index, 10.1046/j.1365-2990.1999.00203.x
  7. Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison D, Genetic abnormalities detected in ependymomas by comparative genomic hybridisation, 10.1038/sj.bjc.6600180
  8. Chan MW, Clin Cancer Res, 8, 464 (2002)
  9. Clark Susan J, Melki John, DNA methylation and gene silencing in cancer: which is the guilty party?, 10.1038/sj.onc.1205598
  10. Costello Joseph F., Frühwald Michael C., Smiraglia Dominic J., Rush Laura J., Robertson Gavin P., Gao Xin, Wright Fred A., Feramisco Jamison D., Peltomäki Päivi, Lang James C., Schuller David E., Yu Li, Bloomfield Clara D., Caligiuri Michael A., Yates Allan, Nishikawa Ryo, Su Huang H.-J., Petrelli Nicholas J., Zhang Xueli, O'Dorisio M. S., Held William A., Cavenee Webster K., Plass Christoph, Aberrant CpG-island methylation has non-random and tumour-type–specific patterns, 10.1038/72785
  11. Dong Shumin, Pang Jesse Chung-sean, Hu Jie, Zhou Liang-fu, Ng Ho-keung, Transcriptional inactivation of TP73 expression in oligodendroglial tumors, 10.1002/ijc.10204
  12. Esteller Manel, Garcia-Foncillas Jesus, Andion Esther, Goodman Steven N., Hidalgo Oscar F., Vanaclocha Vicente, Baylin Stephen B., Herman James G., Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents, 10.1056/nejm200011093431901
  13. Esteller M, Cancer Res, 60, 129 (2000)
  14. Fueyo J, Oncogene, 13, 1615 (1996)
  15. Hamilton RL, Brain Pathol, 7, 807 (1997)
  16. Herman J. G., Graff J. R., Myohanen S., Nelkin B. D., Baylin S. B., Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands., 10.1073/pnas.93.18.9821
  17. Herman JG, Cancer Res, 56, 722 (1996)
  18. Hirose Yuichi, Aldape Kenneth, Bollen Andrew, James C. David, Brat Daniel, Lamborn Kathleen, Berger Mitchel, Feuerstein Burt G., Chromosomal Abnormalities Subdivide Ependymal Tumors into Clinically Relevant Groups, 10.1016/s0002-9440(10)64061-8
  19. Ichimura K, Cancer Res, 60, 417 (2000)
  20. Issa Jean-Pierre, Aging, DNA methylation and cancer, 10.1016/s1040-8428(99)00019-0
  21. Izumoto Shuichi, Arita Norio, Ohnishi Takanori, Hiraga Shoju, Taki Takuyu, Hayakawa Toru, Homozygous deletions of p16INK4A/MTS1 and p15INK4B/MTS2 genes in glioma cells and primary glioma tissues, 10.1016/0304-3835(95)03981-2
  22. Jen J, Cancer Res, 54, 6353 (1994)
  23. Jones Peter A, Laird Peter W, 10.1038/5947
  24. Kleihues P, Pathology and Genetics. Tumours of the Nervous System (2000)
  25. Korshunov A, Acta Neuropathol (Berl), 102, 271 (2001)
  26. Lecomte Thierry, Berger Anne, Zinzindohoué Franck, Micard Stéphanie, Landi Bruno, Blons Hélène, Beaune Philippe, Cugnenc Paul-Henri, Laurent-Puig Pierre, Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis : Plasma DNA in Colorectal Cancer Patients, 10.1002/ijc.10526
  27. Mazewski Claire, Soukup Shirley, Ballard Edgar, Gotwals Betsy, Lampkin Beatrice, Karyotype Studies in 18 Ependymomas with Literature Review of 107 Cases, 10.1016/s0165-4608(99)00046-1
  28. Nakamura M, Brain Pathol, 11, 159 (2001)
  29. Nakamura Mitsutoshi, Yonekawa Yasuhiro, Kleihues Paul, Ohgaki Hiroko, Promoter Hypermethylation of the RB1 Gene in Glioblastomas, 10.1038/labinvest.3780213
  30. Park Sung Hye, Jung Kyeong Cheon, Ro Jae Y, Kang Gyeong Hoon, Khang Shin Kwang, 5' CpG island methylation of p16 is associated with absence of p16 expression in glioblastomas, 10.3346/jkms.2000.15.5.555
  31. Robertson Keith D, DNA methylation and chromatin – unraveling the tangled web, 10.1038/sj.onc.1205609
  32. Ruas Margarida, Peters Gordon, The p16INK4a/CDKN2A tumor suppressor and its relatives, 10.1016/s0304-419x(98)00017-1
  33. Scheil S, Brain Pathol, 11, 133 (2001)
  34. Singh PK, Mod Pathol, 15, 526 (2002)
  35. Toyota M., Ahuja N., Ohe-Toyota M., Herman J. G., Baylin S. B., Issa J.-P. J., CpG island methylator phenotype in colorectal cancer, 10.1073/pnas.96.15.8681
  36. Watanabe T, Acta Neuropathol (Berl), 101, 185 (2001)
  37. Watanabe Takao, Yokoo Hideaki, Yokoo Minako, Yonekawa Yasuhiro, Kleihues Paul, Ohgaki Hiroko, Concurrent Inactivation of RB1 and TP53 Pathways in Anaplastic Oligodendrogliomas, 10.1093/jnen/60.12.1181
  38. Wolter Marietta, Reifenberger Julia, Blaschke Britta, Ichimura Koichi, Schmidt Esther E., Collins V. Peter, Reifenberger Guido, Oligodendroglial Tumors Frequently Demonstrate Hypermethylation of theCDKN2A(MTS1, p16INK4a),p14ARF, andCDKN2B(MTS2,p15INK4b) Tumor Suppressor Genes, 10.1093/jnen/60.12.1170
  39. Wong DJ, Cancer Res, 57, 2619 (1997)
  40. Wong IH, Blood, 95, 1942 (2000)
  41. Zhang L, Proc Natl Acad Sci USA, 89, 5847 (1992)
  42. Zheng Ping-pin, Pang Jesse Chung-sean, Hui Angela Bik-yu, Ng Ho-keung, Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas, 10.1016/s0165-4608(00)00265-x